VitaNova Life Sciences reported revenue of $1.78M and net income of $0.02M for the quarter ended Apr 2026, down 8.6% year over year. This income statement covers 37 quarters of results from Apr 2017 through Apr 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Apr2017 | Jul2017 | Oct2017 | Jan2018 | Apr2018 | Jul2018 | Oct2018 | Jan2019 | Apr2019 | Jul2019 | Oct2019 | Jan2020 | Apr2020 | Jul2020 | Oct2020 | Jan2021 | Apr2021 | Jul2021 | Oct2021 | Jan2022 | Apr2022 | Jul2022 | Oct2022 | Jan2023 | Apr2023 | Jul2023 | Oct2023 | Jan2024 | Apr2024 | Jul2024 | Oct2024 | Jan2025 | Apr2025 | Jul2025 | Oct2025 | Jan2026 | Apr2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | |||||||||||||||||||||||||||||||||||||
| Revenue | 0.04M | 0.03M | 0.04M | 0.01M | 0.01M | 0.01M | 0.00M | 0.03M | 0.54M | 0.11M | 0.29M | 0.31M | 1.95M | 0.10M | 0.43M | 0.71M | 1.78M | ||||||||||||||||||||
| Cost of RevenueCost of Rev | 0.19M | 0.04M | 0.14M | 0.12M | 0.80M | 0.04M | 0.17M | 0.39M | 1.52M | ||||||||||||||||||||||||||||
| Gross Profit | 0.03M | 0.35M | 0.07M | 0.16M | 0.19M | 1.16M | 0.07M | 0.26M | 0.32M | 0.26M | |||||||||||||||||||||||||||
| Operating items | |||||||||||||||||||||||||||||||||||||
| Selling, General & AdministrativeSG&A | 0.01M | 0.03M | 0.02M | 0.07M | 0.01M | 0.01M | 0.03M | 0.01M | 0.02M | 0.01M | 0.02M | 0.03M | 0.06M | 0.04M | 0.03M | 0.03M | 0.07M | 0.12M | 0.22M | 0.33M | |||||||||||||||||
| Other Operating ExpensesOther Opex | 0.09M | 0.06M | 0.05M | 0.05M | 0.05M | 0.03M | 0.04M | 0.05M | 0.05M | ||||||||||||||||||||||||||||
| Operating ExpensesOpex | 0.01M | 0.03M | 0.02M | 0.07M | 0.01M | 0.01M | 0.03M | 0.01M | 0.02M | 0.01M | 0.02M | 0.12M | 0.12M | 0.09M | 0.08M | 0.08M | 0.10M | 0.16M | 0.27M | 0.37M | |||||||||||||||||
| Operating IncomeOp. Inc | -0.01M | -0.03M | 0.00M | -0.02M | -0.01M | 0.01M | 0.23M | -0.05M | 0.06M | 0.11M | 1.08M | -0.03M | 0.10M | 0.05M | -0.11M | ||||||||||||||||||||||
| EBIT | -0.01M | -0.03M | 0.01M | -0.03M | 0.00M | 0.00M | -0.02M | -0.00M | -0.02M | -0.01M | 0.01M | 0.23M | -0.05M | 0.06M | 0.11M | 1.08M | -0.03M | 0.10M | 0.05M | -0.11M | |||||||||||||||||
| Non-operating items | |||||||||||||||||||||||||||||||||||||
| Non Operating Interest Expenses | 0.00M | 813.00 | 0.00M | ||||||||||||||||||||||||||||||||||
| Other Non Operating IncomeOther Non Op Inc. | 0.15M | 105.00 | 300.00 | 196.00 | 120.00 | -0.00M | |||||||||||||||||||||||||||||||
| Non Operating IncomeNon Op. Inc. | 0.15M | 105.00 | -0.00M | -617.00 | -0.00M | 120.00 | 0.00M | ||||||||||||||||||||||||||||||
| Net income details | |||||||||||||||||||||||||||||||||||||
| EBT | 0.14M | 0.02M | 0.01M | -0.03M | 0.00M | 0.00M | -0.02M | -0.00M | -0.02M | -0.01M | 0.01M | 0.23M | -0.05M | 0.06M | 0.11M | 1.08M | -0.03M | 0.10M | 0.05M | -0.11M | |||||||||||||||||
| Tax ProvisionsTaxes | 0.06M | 0.01M | 0.03M | 0.04M | 0.28M | 0.01M | 0.06M | 0.09M | -0.12M | ||||||||||||||||||||||||||||
| Profit After TaxPAT | 0.14M | 0.02M | 0.01M | -0.03M | 0.00M | 0.00M | -0.02M | -0.00M | -0.02M | -0.01M | 0.01M | 0.17M | -0.06M | 0.03M | 0.07M | 0.80M | -0.05M | 0.04M | -0.04M | 0.02M | |||||||||||||||||
| Income from Continuing OperationsIncome (Continuing) | 0.14M | 0.02M | 0.01M | -0.03M | 0.00M | 0.00M | -0.02M | -0.00M | -0.02M | -0.01M | 0.01M | 0.17M | -0.06M | 0.03M | 0.07M | 0.80M | -0.05M | 0.04M | -0.04M | 0.02M | |||||||||||||||||
| Income from Discontinued OperationsIncome (Discontinued) | |||||||||||||||||||||||||||||||||||||
| Consolidated Net IncomeConsol Net Inc. | 0.14M | 0.02M | 0.01M | -0.03M | 0.00M | 0.00M | -0.02M | -0.00M | -0.02M | -0.01M | 0.01M | 0.17M | -0.06M | 0.03M | 0.07M | 0.80M | -0.05M | 0.04M | -0.04M | 0.02M | |||||||||||||||||
| Income towards Parent CompanyParent Net Inc | 0.14M | 0.02M | 0.01M | -0.03M | 0.00M | 0.00M | -0.02M | -0.00M | -0.02M | -0.01M | 0.01M | 0.17M | -0.06M | 0.03M | 0.07M | 0.80M | -0.05M | 0.04M | -0.04M | 0.02M | |||||||||||||||||
| Net Income towards Common StockholdersNet Income | 0.14M | 0.02M | 0.01M | -0.03M | 0.00M | 0.00M | -0.02M | -0.00M | -0.02M | -0.01M | 0.01M | 0.17M | -0.06M | 0.03M | 0.07M | 0.80M | -0.05M | 0.04M | -0.04M | 0.02M | |||||||||||||||||
| Additional items | |||||||||||||||||||||||||||||||||||||
| EPS (Basic) | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 | 0.03 | 0.00 | 0.00 | -0.01 | 0.00 | |||||||||||||||||
| EPS (Diluted) | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 | 0.03 | 0.00 | 0.00 | -0.01 | 0.00 | |||||||||||||||||
| Shares Outstanding | 5.87M | 5.87M | 5.87M | 5.87M | 5.87M | 5.87M | 5.87M | 5.87M | 5.87M | 5.87M | 6.08M | 10.64M | 25.01M | 25.01M | 25.01M | 25.01M | 25.01M | 25.01M | 8.34M | 8.34M | |||||||||||||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 5.87M | 5.87M | 5.87M | 5.87M | 5.87M | 5.87M | 5.87M | 5.87M | 5.87M | 5.87M | 6.08M | 10.64M | 25.01M | 25.01M | 25.01M | 25.01M | 25.01M | 25.01M | 8.34M | 8.34M | |||||||||||||||||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 5.87M | 5.87M | 5.87M | 5.87M | 5.87M | 5.87M | 5.87M | 5.87M | 5.87M | 5.87M | 6.08M | 10.64M | 25.01M | 25.01M | 25.01M | 25.01M | 25.01M | 25.01M | 8.34M | 8.34M | |||||||||||||||||
| EBITDA | -0.01M | -0.03M | 0.01M | -0.03M | 0.00M | 0.00M | -0.02M | -0.00M | -0.02M | -0.01M | 0.01M | 0.23M | -0.05M | 0.06M | 0.11M | 1.08M | -0.03M | 0.10M | 0.05M | -0.11M | |||||||||||||||||
| Interest ExpensesInt Expense | 0.00M | 813.00 | 0.00M | ||||||||||||||||||||||||||||||||||
| Tax Rate | 27.87% | -21.57% | 46.28% | 32.59% | 25.94% | -42.73% | 63.93% | 194.93% | 116.40% |